Cargando…

T cell receptor dynamic and transcriptional determinants of T cell expansion in glioma-infiltrating T cells

BACKGROUND: Glioblastoma (GBM) is characterized by low numbers of glioma-infiltrating lymphocytes (GIL) with a dysfunctional phenotype. Whether this dysfunctional phenotype is fixed or can be reversed upon ex vivo culturing is poorly understood. The aim of this study was to assess T cell receptor (T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Kevin Hai-Ning, Michel, Julius, Kilian, Michael, Aslan, Katrin, Qi, Hao, Kehl, Niklas, Jung, Stefanie, Sanghvi, Khwab, Lindner, Katharina, Zhang, Xin-Wen, Green, Edward W, Poschke, Isabel, Ratliff, Miriam, Bunse, Theresa, Sahm, Felix, von Deimling, Andreas, Wick, Wolfgang, Platten, Michael, Bunse, Lukas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Basic and Translational Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526356/ https://www.ncbi.nlm.nih.gov/pubmed/36196364 http://dx.doi.org/10.1093/noajnl/vdac140

Ejemplares similares

Comparative evaluation of T-cell receptors in experimental glioma-draining lymph nodes
por: Blobner, Jens, et al.
Publicado: (2021)

Dysfunctional dendritic cells limit antigen-specific T cell response in glioma
por: Friedrich, Mirco, et al.
Publicado: (2022)

T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas
por: Kilian, Michael, et al.
Publicado: (2022)

Genetically Modified Cellular Therapies for Malignant Gliomas
por: Kilian, Michael, et al.
Publicado: (2021)

K27M-mutant histone-3 as a novel target for glioma immunotherapy
por: Ochs, Katharina, et al.
Publicado: (2017)

Molecular profiling-based decision for targeted therapies in IDH wild-type glioblastoma
por: Kessler, Tobias, et al.
Publicado: (2020)

A vaccine targeting mutant IDH1 in newly diagnosed glioma
por: Platten, Michael, et al.
Publicado: (2021)

INTERCEPT H3: a multicenter phase I peptide vaccine trial for the treatment of H3-mutated diffuse midline gliomas
por: Grassl, Niklas, et al.
Publicado: (2023)

Intrathecal activation of CD8(+) memory T cells in IgG4‐related disease of the brain parenchyma
por: Friedrich, Mirco, et al.
Publicado: (2021)

AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomas
por: Bunse, Lukas, et al.
Publicado: (2022)

In vivo nanoparticle-based T cell imaging can predict therapy response towards adoptive T cell therapy in experimental glioma
por: Hunger, Jessica, et al.
Publicado: (2023)

Emerging targets for anticancer vaccination: IDH
por: Platten, M., et al.
Publicado: (2021)

AAMP is a binding partner of costimulatory human B7-H3
por: Ciprut, Sara, et al.
Publicado: (2022)

Clinical and Translational Advances in Glioma Immunotherapy
por: Bunse, Lukas, et al.
Publicado: (2022)

Site-Specific Considerations on Engineered T Cells for Malignant Gliomas
por: Elmadany, Nirmeen, et al.
Publicado: (2022)

A H3K27M-targeted vaccine in adults with diffuse midline glioma
por: Grassl, Niklas, et al.
Publicado: (2023)

Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas
por: Aslan, Katrin, et al.
Publicado: (2020)

Single-cell transcriptomic analyses provide insights into the cellular origins and drivers of brain metastasis from lung adenocarcinoma
por: Wang, Zihao, et al.
Publicado: (2023)

GBMdeconvoluteR accurately infers proportions of neoplastic and immune cell populations from bulk glioblastoma transcriptomics data
por: Ajaib, Shoaib, et al.
Publicado: (2023)

Increased IgG4 responses to multiple food and animal antigens indicate a polyclonal expansion and differentiation of pre-existing B cells in IgG4-related disease
por: Culver, Emma L, et al.
Publicado: (2015)

Distinct difference in tumor-infiltrating immune cells between Wilms’ tumor gene 1 peptide vaccine and anti-programmed cell death-1 antibody therapies
por: Yokota, Chisato, et al.
Publicado: (2021)

Akaluc bioluminescence offers superior sensitivity to track in vivo glioma expansion
por: Bozec, Dominique, et al.
Publicado: (2020)

IgE type multiple myeloma exhibits hypermutated phenotype and tumor reactive T cells
por: Kehl, Niklas, et al.
Publicado: (2022)

Premature senescence of T-cell subsets in axial spondyloarthritis
por: Fessler, Johannes, et al.
Publicado: (2016)

A novel program of infiltrative control in astrocytomas: ADAM23 depletion promotes cell invasion by activating γ-secretase complex
por: Jandrey, Elisa Helena Farias, et al.
Publicado: (2023)

Promotion of Glioblastoma Cell Motility by Enhancer of Zeste Homolog 2 (EZH2) Is Mediated by AXL Receptor Kinase
por: Ott, Martina, et al.
Publicado: (2012)

The STAT4 SLE risk allele rs7574865[T] is associated with increased IL-12-induced IFN-γ production in T cells from patients with SLE
por: Hagberg, Niklas, et al.
Publicado: (2018)

Glioma stem cells activate platelets by plasma-independent thrombin production to promote glioblastoma tumorigenesis
por: Sloan, Anthony R, et al.
Publicado: (2022)

Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis
por: Yeo, Lorraine, et al.
Publicado: (2011)

Programmed death ligand 1 gene silencing in murine glioma models reveals cell line-specific modulation of tumor growth in vivo
por: Blomberg, Evelina, et al.
Publicado: (2022)

Novel strategy for manufacturing autologous dendritic cell/allogeneic tumor lysate vaccines for glioblastoma
por: Parney, Ian F, et al.
Publicado: (2020)

A distinct pattern of growth and RAC1 signaling in melanoma brain metastasis cells
por: Stejerean-Todoran, Ioana, et al.
Publicado: (2022)

Pediatric brain tumor cancer stem cells: cell cycle dynamics, DNA repair, and etoposide extrusion
por: Hussein, Deema, et al.
Publicado: (2011)

B cell OX40L supports T follicular helper cell development and contributes to SLE pathogenesis
por: Cortini, Andrea, et al.
Publicado: (2017)

Single-cell image analysis reveals a protective role for microglia in glioblastoma
por: Woolf, Zoe, et al.
Publicado: (2021)

ALCAM contributes to brain metastasis formation in non-small-cell lung cancer through interaction with the vascular endothelium
por: Münsterberg, Justine, et al.
Publicado: (2020)

Chimeric antigen receptor T cell-based targeting of CD317 as a novel immunotherapeutic strategy against glioblastoma
por: Hänsch, Lena, et al.
Publicado: (2023)

Synovial CD4+ T-cell-derived GM-CSF supports the differentiation of an inflammatory dendritic cell population in rheumatoid arthritis
por: Reynolds, G, et al.
Publicado: (2016)

A new in vitro model of polymyositis reveals CD8(+) T cell invasion into muscle cells and its cytotoxic role
por: Kamiya, Mari, et al.
Publicado: (2020)

Brief Report: Effect of CMV and HIV Transcription on CD57 and PD-1 T-Cell Expression During Suppressive ART
por: Dan, Jennifer M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_eq12vrn4ack67n4aocdj205she